Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties. Using the approach, scientists exchanged one chemical group for another in 39 cancer drugs—and discovered under lab conditions that the chemically altered versions of three of the drugs had more potent anti-cancer activity.
The results, published today in the Journal of the American Chemical Society, reveal a powerful application of so-called “click chemistry” to drug discovery.
“Usually you have to make thousands or millions of molecules and go through a big screening process to find one or two molecules that are interesting and might work,” says Peng Wu, PhD, a TSRI associate professor and one of the study’s lead authors. “With this new approach, you can save time and money by starting with drugs and molecules you know are already active and asking whether a quick modification makes any of them any better.”
“Our results suggest we will be able take a drug and make it more potent, faster acting, and hopefully with better bioavailability,” adds Nobel laureate K. Barry Sharpless, PhD, who co-led the study.
Sharpless, the TSRI W.M. Keck Professor of Chemistry, first conceived of click chemistry in the 1990s. Click chemistry is the term for simple molecular reactions that can each be carried out in one container, undisturbed by water, and generate just one stable product at high yield. Sharpless compares the method to decorating molecules like Christmas trees, adding a new functional “ornament” to one of a molecule’s branches, which he calls “clickable hubs.”
“Instead of pursuing leads, which is the traditional method, SuFEx click chemistry is about connecting promising drug candidates directly with targets,” says Sharpless.
One of the latest click chemistry reactions developed by Sharpless’ group was Sulfur (VI) Fluoride Exchange (SuFEx), which transforms any phenol chemical group into a fluorosulfate. Because fluorosulfates have some benefits over phenols—including tighter binding to proteins, and less ability to be modified in the cell—the SuFEx reaction offers a way to potentially improve phenol drugs.
However, the transformation typically relies on sulfuryl fluoride gas, which makes it hard to perform on many different molecules at the same time; each reaction must be carried out in its own flask.
In the new paper, Sharpless and Wu show that sulfuryl fluoride gas can be dissolved in an organic solvent to make a liquid form of the reagent needed for SuFEx. “Now, suddenly, we can use this in high-throughput experiments,” says Wu.
To test the reaction’s utility in drug discovery, Sharpless, Wu and their colleagues put 39 existing cancer drugs containing phenols into plates, added the liquid version of sulfuryl fluoride to each well, and exposed cancer cells to both the original compounds and the resulting fluorosulfate versions. In three instances, the new fluorosulfate drug killed more cancer cells than the original version. When modified with SuFEx, the breast cancer drug Fulvestrant had a great effect on estrogen receptors in breast cancer cells, and the cancer drug Combretastatin A4 was 70 times more potent against colon cancer cells.
Upon further examination, the researchers discovered that the new molecules bound to their molecular targets better and were less apt to be metabolized by the cells.
“We think our approach is generally applicable to drug modification outside of just cancer drugs,” says Wu. The team is already using the new high-throughput SuFEx to modify drugs targeting the immune system’s T cells, he adds.
Learn more: ‘Click chemistry’ reactions may boost cancer-fighting drug potency
The Latest on: Click chemistry
[google_news title=”” keyword=”Click chemistry” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Click chemistry
- ‘Like kissing Hitler’: The stars who failed Hollywood’s ‘chemistry test’on April 24, 2024 at 7:00 am
Imagine, for a moment, that you’re an actress at the beginning of your career. You’ve been acclaimed for your performances on stage – your Ophelia was the talk of the National Theatre, and your ...
- Backed by $1 billion, former Stanford President Marc Tessier-Lavigne heading AI-focused biotech startupon April 23, 2024 at 11:52 am
Ex-Stanford President Marc Tessier-Lavigne is now leading a $1 billion+ AI-focused biotech that includes a who's-who of biotech players ...
- “Click” Chemistry Helps To Create Over 150 Potential Drug Compoundson April 4, 2024 at 5:00 pm
Moses calls his innovative process Accelerated SuFEx Click Chemistry (ASCC). It’s one of the latest advances in the Nobel-winning field of click chemistry, pioneered by Moses’ mentor K. Barry ...
- Click chemistry: Research team creates 150 new compoundson April 4, 2024 at 12:04 pm
Moses calls his innovative process Accelerated SuFEx Click Chemistry (ASCC). It's one of the latest advances in the Nobel-winning field of click chemistry, pioneered by Moses' mentor, K.
- Click, click, boom—150 new moleculeson April 3, 2024 at 5:00 pm
Moses calls his innovative process Accelerated SuFEx Click Chemistry (ASCC). It’s one of the latest advances in the Nobel-winning field of click chemistry, pioneered by Moses’ mentor K.
- Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Includedon March 3, 2024 at 4:00 pm
Alfa Chemistry, a leading chemical supplier and service provider, has recently announced the expansion of their selection of click chemistry reagents. This development aims to better serve the needs ...
- Click Chemistry: On atoms and moleculeson February 11, 2024 at 9:32 pm
Such a sense of inquisitiveness and visual memory led him towards click chemistry for which he won the Nobel Prize in Chemistry in 2022 with US scientists Carolyn Bertozzi and Karl Barry Sharpless.
- Click and bio-orthogonal chemistry take Nobel Prize 2022on October 5, 2022 at 5:00 pm
While Bertozzi took the prize for elevating click chemistry to a new dimension and employing it in living organisms, Sharpless and Meldal were awarded for their work in laying the very foundations ...
- “Click chemistry” developers awarded Nobel Prizeon October 5, 2022 at 5:00 pm
The winners were chosen “for the development of click chemistry and bioorthogonal chemistry,” the organizers explained in a more technical manner. Bertozzi is based at Stanford University in ...
- Click chemistry combats canceron August 8, 2019 at 2:03 am
The complexes were formed using the principles of "click chemistry" – that's a way to join small modular units into longer chains, similar to processes in nature. These reactions have many positive ...
via Bing News